INDOLE AND AZAINDOLE MODULATORS OF THE ALPHA 7 NACHR
申请人:Dinnell Kevin
公开号:US20120283273A1
公开(公告)日:2012-11-08
This invention relates to modulation of the α7 nicotinic acetylcholine receptor (nAChR) by a compound of formula (I) or a pharmaceutically acceptable salt thereof.
本发明涉及利用式(I)的化合物或其药学上可接受的盐来调节α7尼古丁酰胆碱受体(nAChR)的方法。
Indole and azaindole modulators of the alpha 7 nAChR
申请人:Proximagen Limited
公开号:US20150005321A1
公开(公告)日:2015-01-01
This invention relates to modulation of the α7 nicotinic acetylcholine receptor (nAChR) by a compound of formula (I):
or a pharmaceutically acceptable salt thereof.
Indole and azaindole modulators of the alpha 7 nachr
申请人:Dinnell Kevin
公开号:US08796283B2
公开(公告)日:2014-08-05
This invention relates to modulation of the α7 nicotinic acetylcholine receptor (nAChR) by a compound of formula (I):
or a pharmaceutically acceptable salt thereof.
[EN] INDOLE AND AZAINDOLE MODULATORS OF THE ALPHA 7 NACHR<br/>[FR] MODULATEURS INDOLES ET AZAINDOLES DU NACHR-?7
申请人:PROXIMAGEN LTD
公开号:WO2011045353A1
公开(公告)日:2011-04-21
This invention relates to modulation of the α7 nicotinic acetylcholine receptor (nAChR) by a compound of formula (I) or a pharmaceutically acceptable salt thereof.